A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease

Summary

The purpose of the study was to evaluate the efficacy and safety of HS-10390 in participants with chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) ≥ 30 and \<90 mL/min/1.73 m\^2, and urinary albumin to creatinine ratio (UACR) ≥ 150 mg/g and \< 3000 mg/g

Timeline

Start

2026-05-21

Primary completion

2027-11-11

Completion

2028-12-31

Drugs

Indications